The East Forum EBMT Nurses Group (NG) consists of nurses and other healthcare professionals from Central and East Europe transplant centres in the EBMT Outreach countries. Recently, 23 transplant centres from 9 countries have cooperated. The Forum activities are in concordance with those of the EBMT-NG: to improve and promote quality and further development of haematopoietic stem cell transplantation nursing.
Oral mucositis (OM) remains a significant medical and nursing problem in the high-dose chemotherapy and haematopoietic SCT setting. Recently, several evidencebased recommendations and guidelines on OM prophylaxis and care have been presented; for example, the MASCC (Multinational Association of Supportive Care in Cancer), NCCN (National Comprehensive Cancer Network) and ESMO (European Society for Medical Oncology). [1] [2] [3] [4] [5] The East Forum has also acknowledged the importance of protocolized and evidence-based nursing and has promoted several research projects and discussions on nursing problems in an attempt to find an international consensus on some of these. The East Forum is aware of the importance of the EBMT Outreach countries' multicentre cooperation, which can substantially help promote transplant nursing, nursing procedures and research.
In October 2009, the Forum started discussions on OM care in an attempt to find an international consensus on minimum necessary and generally applicable management. The draft of the OM care Standard, which was based on the above-mentioned guidelines [1] [2] [3] [4] [5] and clinical experience, comments of individual centres and the results of regional international trials, 6 was presented to the Forum in March 2010 and later accepted. The Standard represents the minimum necessary care that should and can easily be provided to patients in every transplant centre within the East Forum. The use of chlorhexidine solutions is primarily not recommended for the treatment of OM or ulcerative OM. However, it can be used to help improve oral hygiene. 3, 7 The goal of the Standard is to minimize the incidence, severity and complications associated with OM. The minimum requirements are:
1. After admission of a patient into the transplant unit, inform him/her about the risk of OM development and oral care principles. 2. Recommend the following basic care: for oral rinses (mouth washes) use solutions that are non-irritating, non-toxic and pleasant for the patient. Always rinse the oral cavity after eating or more frequently, but at least three times a day. It is not necessary to use antimicrobial solutions unless a local infection is present or any other specific indication arises (see the point 5). Teeth should be cleaned regularly with a soft toothbrush. If there is gum bleeding, the mouth should be rinsed with selected solutions and the teeth wiped with a small brush or gauze dipped in the solution. Dentures should be cleaned regularly and removed during the night and, in the event of painful OM, during the day as well. 3. If OM develops, the care specified above should be continued. 4. Oral cryotherapy should be used in patients with bolus or short-infusion (15-min) melphalan, fluorouracil or adetrexate. The patient should be instructed to start sucking, rinsing or gargling ice-cold water, ice cubes or crushed ice 5 min before chemotherapy administration and to continue this procedure during chemotherapy administration (maximum 15 min infusion) and for 15 min thereafter. The patient may spit out the cold water, but gargling and swallowing it occasionally can help prevent pharyngeal and oesophageal mucositis. Cryotherapy can be stopped whenever the patient wishes. 5. In cases of severe ulcerative OM, local infection or bleeding, it is preferable to use anti-microbial solutions for rinsing (for example, solutions of chlorhexidine, povidon-iodine), but always with respect to the preference and tolerance of the patient (regular and careful rinsing is the most important action even if no antimicrobial solutions are given). 6. In cases of oral pain, local protective viscous gels or solutions with local anaesthetic should be offered (but beware of the possibility of local anaesthetic absorption, overall toxicity and limitations of swallowing ability). Treatment with i.v. analgesics (for example, tramadol) and opiates should be agreed upon by the physician.
7. The patient should be consulted daily about the condition of the oral cavity, and the ability to eat and drink. 8. Development of OM should be evaluated daily. Examine the oral cavity carefully, using a torch and tongue depressor. Individual areas of the oral cavity should be evaluated daily and the grade of the OM assessed according to the WHO criteria (Table 1) ; pain should be evaluated according to visual analogue scale ( Table 2 ). 9. Where infection is suspected within the oral cavity, the physician should be informed and smears taken for microbiological and mycological testing.
